[Cancerogenic effects of immunosuppressive agents?]. 1969

C G Schmidt

UI MeSH Term Description Entries
D007166 Immunosuppressive Agents Agents that suppress immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-CELLS or by inhibiting the activation of HELPER CELLS. While immunosuppression has been brought about in the past primarily to prevent rejection of transplanted organs, new applications involving mediation of the effects of INTERLEUKINS and other CYTOKINES are emerging. Immunosuppressant,Immunosuppressive Agent,Immunosuppressants,Agent, Immunosuppressive,Agents, Immunosuppressive
D009369 Neoplasms New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms. Benign Neoplasm,Cancer,Malignant Neoplasm,Tumor,Tumors,Benign Neoplasms,Malignancy,Malignant Neoplasms,Neoplasia,Neoplasm,Neoplasms, Benign,Cancers,Malignancies,Neoplasias,Neoplasm, Benign,Neoplasm, Malignant,Neoplasms, Malignant
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

C G Schmidt
January 1997, Anales de la Real Academia Nacional de Medicina,
C G Schmidt
November 1964, Bollettino chimico farmaceutico,
C G Schmidt
January 1983, Bulletin du cancer,
C G Schmidt
January 1996, Alimentary pharmacology & therapeutics,
C G Schmidt
September 1971, Arzneimittel-Forschung,
C G Schmidt
January 2003, Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia,
C G Schmidt
June 1960, Cancer research,
C G Schmidt
January 1953, Acta - Unio Internationalis Contra Cancrum,
C G Schmidt
January 1953, Acta - Unio Internationalis Contra Cancrum,
Copied contents to your clipboard!